---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-064067"
form_type: "8-K"
ticker: "DCGO"
cik: "0001822359"
company_name: "DocGo Inc."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T04:46:20.303674+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# DocGo Q2 revenue $125.5M, raises FY2023 revenue guidance to $540-550M

## Summary
- Total revenue $125.5M, up 15% sequentially; net income $1.3M vs net loss $3.9M in Q1.
- Excluding mass COVID-testing (under $1M), core revenue grew 53% YoY.
- FY2023 revenue guidance raised to $540-550M, Adjusted EBITDA guidance to $48-53M.
- Backlog increased to $325M from $205M as of May 8, driven by Mobile Health wins.
- Cash $123.8M, no material debt, $90M undrawn credit line.

## SEC filing metadata
- accession: 0001213900-23-064067
- form_type: 8-K
- ticker: DCGO
- cik: 0001822359
- company_name: DocGo Inc.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822359/000121390023064067/0001213900-23-064067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822359/000121390023064067/ea182961-8k_docgo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-064067
- JSON: https://secwatch.observer/filing/0001213900-23-064067.json
- Plain text: https://secwatch.observer/filing/0001213900-23-064067.txt

## Key facts
- Earnings Releases
  DocGo Inc. reported the quarter ended June 30, 2023 results: revenue $125.5 million, net income $1.3 million. Guidance raised.
  - Period: the quarter ended June 30, 2023
  - Revenue: $125.5 million
  - Net income: $1.3 million
  - Guidance: raised
  - Result: reported results
  source text: services today announced financial and operating results for the quarter ended June 30, 2023. Q2 2023 Financial Highlights ● Total revenue for the second quarter of 2023 was $125.5 million, up from $113.0 million in the first quarter of 2023 and $109.5 million in the second quarter of 2022. Mass COVID-testing revenues during each of the first two quarters of 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822359/000121390023064067/0001213900-23-064067-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.